Respiratory medicine is one frontier of the global healthcare landscape which has undergone significant transformations in ...

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...

The longer you smoke, the more you risk causing chronic inflammation or swelling in the lungs and the greater your risk of developing lung cancer, including lung cancer and COPD ... breathing ...

Extrafine single inhaler triple therapy is effective among patients with COPD who were previously treated with multiple-inhaler triple therapy.

The FDA has approved Dupixent (dupilumab) as an add-on therapy for adults with poorly controlled COPD, especially those with ...

RESPICON 2024 organised between 27th and 29th September witnessed a significant milestone in the field of pulmonary medicine ...

China NMPA approves Sanofi & Regeneron’s Dupixent as an add-on maintenance treatment for adults with uncontrolled COPD: Paris Monday, September 30, 2024, 11:00 Hrs [IST] The Nat ...

COPD and BPD: Inhalation of Live Lactobacilli Lessens Lung Inflammation and Improves Lung Function Aug. 21, 2024 — In preclinical models, the inhalation of a mixture of living Lactobacilli ...

Dupixent may help some people with inadequately controlled COPD who have a type of lung inflammation that worsens symptoms.

Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses the impact of changes in lung function in patients with idiopathic pulmonary fibrosis (IPF).

The US Food and Drug Administration (FDA) has announced the approval of Sanofi and Regeneron’s interleukin (IL)-4 and IL-13 ...

Dupixent approved in the US as the first-ever biologic medicine for patients with COPD         Dupixent is indicated for the approximately 300,000 adults in the US with inadequately ...